Side effects can actually undermine results
GLP-1: Limited Driven by nervous system dysregulation: disrupted feeding cycles, altered stress responses, and changes in the neurological architecture governing hunger, satiety, and reward
Jennifer Cheng, DO, chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, told MNT that, right now, GLP-1 microdosing is an experimental approach
doi:10.1093/emph/eoab031 Lvovskaya S, Smith DP
Every product here is sold for research use only
Rather than a quick fix, researchers emphasize that GLP-1 drugs are powerful tools that work best alongside broader approaches to health